精品人妻内射_欧美色色色色色色色色_韩日少妇_女人爽到高潮潮久久久_成人国产草莓视频在线观看 _成人国产无码_日韩成人无码\_色狠狠综合av熟女_久久无码视频在线观看_亚洲小说在线_人碰人人_国模冰莲自慰极品美胞_一级a一级a爱片免费_欧美日本二区_亚洲美女精品

北京索萊寶科技

專注于生物學(xué)試劑及試劑盒領(lǐng)域

服務(wù)熱線:18101056239

產(chǎn)品中心

PRODUCTS CENTER

當(dāng)前位置:首頁(yè)產(chǎn)品中心抗體Polyclonal AntibodyK106634PAnti-PGH2 Polyclonal Antibody

Anti-PGH2 Polyclonal Antibody
產(chǎn)品簡(jiǎn)介:

Anti-PGH2 Polyclonal Antibody
應(yīng)用 IHC
稀釋比例IHC 1:50-200.
交叉反應(yīng)Human

產(chǎn)品型號(hào):K106634P

更新時(shí)間:2022-08-15

廠商性質(zhì):生產(chǎn)廠家

訪 問 量 :918

服務(wù)熱線

010-50973130

立即咨詢
產(chǎn)品介紹

Anti-PGH2 Polyclonal Antibody

英文名稱Anti-PGH2 Polyclonal Antibody
宿主Rabbit
別名PTGS2;COX2;PHS II;PGHS-2
應(yīng)用IHC
稀釋比例IHC 1:50-200.
交叉反應(yīng)Human
蛋白分子量69kDa
Gene ID5743
保存Store at -20°C. Avoid freeze / thaw cycles.
儲(chǔ)存液Buffer: PBS with 0.03% Proclin300, 50% glycerol, pH7.3.
純化方法Affinity purification
亞型IgG
免疫原A synthetic peptide of human PGH2
性狀液體
Public Immunogen RangeA synthetic peptide of human PGH2
Subcellular LocationsCytoplasm
Swiss ProtP35354
克隆類型Polyclonal Antibody
背景資料Converts arachidonate to prostaglandin H2 (PGH2), a committed step in prostanoid synthesis. Constitutively expressed in some tissues in physiological conditions, such as the endothelium, kidney and brain, and in pathological conditions, such as in cancer. PTGS2 is responsible for production of inflammatory prostaglandins. Up-regulation of PTGS2 is also associated with increased cell adhesion, phenotypic changes, resistance to apoptosis and tumor angiogenesis. In cancer cells, PTGS2 is a key step in the production of prostaglandin E2 (PGE2), which plays important roles in modulating motility, proliferation and resistance to apoptosis.

在線留言

ONLINE MESSAGE

留言框

  • 產(chǎn)品:

  • 您的單位:

  • 您的姓名:

  • 聯(lián)系電話:

  • 常用郵箱:

  • 省份:

  • 詳細(xì)地址:

  • 補(bǔ)充說明:

  • 驗(yàn)證碼:

    請(qǐng)輸入計(jì)算結(jié)果(填寫阿拉伯?dāng)?shù)字),如:三加四=7
  • 服務(wù)熱線 010-50973130
  • 電子郵箱

    3193328036@qq.com

掃碼加微信

Copyright © 2025 北京索萊寶科技有限公司版權(quán)所有    備案號(hào):

技術(shù)支持:化工儀器網(wǎng)    sitemap.xml

| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |